Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Letter uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Dose-Response Relationship, Drug
  • Neoplasms, Germ Cell and Embryonal
  • Stem Cell Transplantation
  • Testicular Neoplasms

publication date

  • December 2016

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2016.05.040

PubMed ID

  • 27311362

Additional Document Info

start page

  • 1082

end page

  • 1083

volume

  • 70

number

  • 6